Loading
Latest filing published 29 Dec 2021 for Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.).
No signal scores available.
All filings by William Poncy on record concern Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). The record holds 3 filings, for trades running from 16 October 2018 to 24 December 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 29 December 2021, the filings show an option exercise in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 46 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations